Dentium Co Ltd
KRX:145720
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
55 700
146 800
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Dentium Co Ltd
Dentium Co Ltd
Note Receivable
Dentium Co Ltd
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dentium Co Ltd
KRX:145720
|
Note Receivable
₩13.5B
|
CAGR 3-Years
55%
|
CAGR 5-Years
133%
|
CAGR 10-Years
N/A
|
|
|
B
|
Biodyne Co Ltd
KOSDAQ:314930
|
Note Receivable
₩0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Note Receivable
₩496.6m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-5%
|
|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Note Receivable
-₩310
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
L
|
Lutronic Corp
KOSDAQ:085370
|
Note Receivable
₩1.8B
|
CAGR 3-Years
36%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Dentium Co Ltd
Glance View
Dentium Co., Ltd. engages in the manufacturing of dental supplies and equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2017-03-15. The Company’s products include artificial dental implants, dental Equipment, synthetic bone for dentistry and other dental medical devices.
See Also
What is Dentium Co Ltd's Note Receivable?
Note Receivable
13.5B
KRW
Based on the financial report for Jun 30, 2024, Dentium Co Ltd's Note Receivable amounts to 13.5B KRW.
What is Dentium Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
133%
Over the last year, the Note Receivable growth was 334%. The average annual Note Receivable growth rates for Dentium Co Ltd have been 55% over the past three years , 133% over the past five years .
You don't have any saved screeners yet
